Cargando…
CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1
CD157/BST-1 (a member of the ADP-ribosyl cyclase family) is expressed at variable levels in 97% of patients with acute myeloid leukemia (AML), and is currently under investigation as a target for antibody-based immunotherapy. We used peripheral blood and bone marrow samples from patients with AML to...
Autores principales: | Yakymiv, Yuliya, Augeri, Stefania, Bracci, Cristiano, Marchisio, Sara, Aydin, Semra, D’Ardia, Stefano, Massaia, Massimo, Ferrero, Enza, Ortolan, Erika, Funaro, Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551154/ https://www.ncbi.nlm.nih.gov/pubmed/34707185 http://dx.doi.org/10.1038/s41598-021-00733-5 |
Ejemplares similares
-
CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia
por: Yakymiv, Yuliya, et al.
Publicado: (2019) -
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
por: Augeri, Stefania, et al.
Publicado: (2018) -
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
por: Ortolan, Erika, et al.
Publicado: (2014) -
Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript
por: Ferrero, Enza, et al.
Publicado: (2017) -
Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis
por: Aydin, Semra, et al.
Publicado: (2023)